At a glance
- Originator Azwell
- Class Aniline compounds; Antiarrhythmics; Quinuclidines; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 08 Jul 1998 Discontinued-Preclinical for Arrhythmias in Japan (Unknown route)
- 16 Dec 1994 Suspended-Preclinical for Arrhythmias in Japan (Unknown route)